Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-15-000330
Filing Date
2015-06-29
Accepted
2015-06-29 16:50:01
Documents
1
Group Members
ANTHONY A. FLORENCE JR.DAVID M. MOTTFOREST BASKETTHARRY R. WELLERJON M. SAKODAJOSHUA MAKOWERKRISHNA S. KOLLURINEA 15 GP LLCNEA PARTNERS 15 L.P.NEW ENTERPRISE ASSOCIATES 15 L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 ARCA BIOPHARMA, INC. arca-sch13d_17828.htm SC 13D 497394
  Complete submission text file 0001072613-15-000330.txt   499596
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51477 | Film No.: 15958884
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities IV, LLC (Filed by) CIK: 0001644965 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D